Investigation of Factors Associated With Immunogenicity Labeling Updates and Characteristics of Biologics License Applications.

MLA

Jiang, Ai-Lei, et al. “Investigation of Factors Associated With Immunogenicity Labeling Updates and Characteristics of Biologics License Applications.” Clinical Pharmacology and Therapeutics, vol. 110, no. 5, Nov. 2021, pp. 1381–88. EBSCOhost, https://doi.org/10.1002/cpt.2393.

APA

Jiang, A.-L., Breder, C. D., & Chang, L.-C. (2021). Investigation of Factors Associated With Immunogenicity Labeling Updates and Characteristics of Biologics License Applications. Clinical Pharmacology and Therapeutics, 110(5), 1381–1388. https://doi.org/10.1002/cpt.2393

Chicago

Jiang, Ai-Lei, Christopher D Breder, and Lin-Chau Chang. 2021. “Investigation of Factors Associated With Immunogenicity Labeling Updates and Characteristics of Biologics License Applications.” Clinical Pharmacology and Therapeutics 110 (5): 1381–88. doi:10.1002/cpt.2393.